Research Papers:

Rs488087 single nucleotide polymorphism as predictive risk factor for pancreatic cancers

Emmanuelle Martinez _, Françoise Silvy, Fréderic Fina, Marc Bartoli, Martin Krahn, Fabrice Barlesi, Dominique Figarella-Branger, Juan Iovanna, René Laugier, Mehdi Ouaissi, Dominique Lombardo and Eric Mas

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2015; 6:39855-39864. https://doi.org/10.18632/oncotarget.5627

Metrics: PDF 1601 views  |   HTML 1920 views  |   ?  


Emmanuelle Martinez1,2, Françoise Silvy1,2, Fréderic Fina1,2,3, Marc Bartoli4, Martin Krahn4,5, Fabrice Barlesi1,2,6, Dominique Figarella-Branger1,2,7, Juan Iovanna8,9,10, René Laugier11, Mehdi Ouaissi1,2,12, Dominique Lombardo1,2, Eric Mas1,2

1Aix-Marseille Université, CRO2, Centre de Recherche en Oncologie biologique et Oncopharmacologie, F-13005, Marseille, France

2INSERM, UMR_S 911, F-13005, Marseille, France

3LBM- Assistance Publique Hôpitaux de Marseille, Hôpital Nord, Service de Transfert d’Oncologie Biologique, F-13015, Marseille, France

4Aix-Marseille Université, INSERM, UMR 910, F-13005, Marseille, France

5Assistance Publique Hôpitaux de Marseille, Hôpital de la Timone-Enfants, Département de Génétique Médicale, F-13005, Marseille, France

6Assistance Publique Hôpitaux de Marseille, Hôpital Nord, Service d’Oncologie Multidisciplinaire & Innovation Thérapeutique, F-13915, Marseille, France

7Assistance Publique Hôpitaux de Marseille, Hôpital de la Timone, Service d’Anatomopathologie, F-13005, Marseille, France

8Aix-Marseille Université, CRCM, Centre de Recherche en Cancérologie de Marseille, F-13009, Marseille, France

9INSERM, UMR_S 1068, F-13009, Marseille, France

10CNRS, UMR 7258, F-13009, Marseille, France

11Assistance Publique Hôpitaux de Marseille, Hôpital de la Timone, Service de Gastroentérologie, F-13005, Marseille, France

12Assistance Publique Hôpitaux de Marseille, Hôpital de la Timone, Service de Chirurgie Digestive et Viscérale, F-13005, Marseille, France

Correspondence to:

Eric Mas, e-mail: [email protected]

Dominique Lombardo, e-mail: [email protected]

Keywords: SNP, rs488087, pancreatic cancer

Abbreviations: BSDL, bile-salt-dependent lipase; PDAC, pancreatic ductal adenocarcinoma; PC, pancreatic cancers

Received: June 23, 2015     Accepted: October 05, 2015     Published: October 16, 2015


Pancreatic cancer (PC) is a devastating disease progressing asymptomatically until death within months after diagnosis. Defining at-risk populations should promote its earlier diagnosis and hence also avoid its development. Considering the known involvement in pancreatic disease of exon 11 of the bile salt-dependent lipase (BSDL) gene that encodes variable number of tandem repeat (VNTR) sequences, we hypothesized upon the existence of a genetic link between predisposition to PC and mutations in VNTR loci. To test this, BSDL VNTR were amplified by touchdown-PCR performed on genomic DNA extracted from cancer tissue or blood samples from a French patient cohort and amplicons were Sanger sequenced. A robust method using probes for droplet digital (dd)-PCR was designed to discriminate the C/C major from C/T or T/T minor genotypes. We report that the c.1719C > T transition (SNP rs488087) present in BSDL VNTR may be a useful marker for defining a population at risk of developing PC (occurrence: 63.90% in the PC versus 27.30% in the control group). The odds ratio of 4.7 for the T allele was larger than those already determined for other SNPs suspected to be predictive of PC. Further studies on tumor pancreatic tissue suggested that a germline T allele may favor Kras G12R/G12D somatic mutations which represent negative prognostic factors associated with reduced survival. We propose that the detection of the T allele in rs488087 SNP should lead to an in-depth follow-up of patients in whom an association with other potential risk factors of pancreatic cancer may be present.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 5627